← Open Payments lookup

DEVON SHAPIRO: Open Payments

NPI 1487297859 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$716 in 30 payments from 12 companies in 2025. Trend: 2023 $808 · 2024 $833 · 2025 $716

Food & beverage: $716
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.5$137
Neurocrine BioSciences, Inc.3$93
Janssen Pharmaceuticals, Inc3$79
Otsuka America Pharmaceutical, Inc.3$79
Teva Pharmaceuticals USA, Inc.4$75
Takeda Pharmaceuticals U.S.A., Inc.3$66
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$48
Noven Therapeutics, LLC3$48
Axsome Therapeutics, Inc.1$34
Lundbeck LLC1$28

Products named: HETLIOZ, INGREZZA, AUSTEDO XR, REXULTI, TRINTELLIX, INVEGA SUSTENNA, CAPLYTA, Xelstrym.

Industry payments across FL — which companies pay providers there.